| Patent | Date |
|---|
Transferrin/transferrin receptor-mediated siRNA delivery
Grant 10,138,483 - Chatterton , et al. Nov | 2018-11-27 |
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
Grant 9,752,147 - Chatterton , et al. September 5, 2 | 2017-09-05 |
TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
App 20170145415 - Chatterton; Jon E. ; et al. | 2017-05-25 |
RNAi-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
App 20170073681 - Clark; Abbot F. ; et al. | 2017-03-16 |
Transferrin/transferrin receptor-mediated siRNA delivery
Grant 9,562,230 - Chatterton , et al. February 7, 2 | 2017-02-07 |
RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
Grant 9,550,994 - Clark , et al. January 24, 2 | 2017-01-24 |
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20170009235 - Chatterton; Jon E. ; et al. | 2017-01-12 |
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis
App 20160326533 - Chatterton; Jon E. ; et al. | 2016-11-10 |
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
Grant 9,476,047 - Chatterton , et al. October 25, 2 | 2016-10-25 |
RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis
Grant 9,422,556 - Chatterton , et al. August 23, 2 | 2016-08-23 |
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20160002638 - Chatterton; Jon E. ; et al. | 2016-01-07 |
RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis
App 20150344886 - Chatterton; Jon E. ; et al. | 2015-12-03 |
TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
App 20150315592 - Chatterton; Jon E. ; et al. | 2015-11-05 |
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
Grant 9,173,896 - Chatterton , et al. November 3, 2 | 2015-11-03 |
Rnai-mediatred Inhibition Of Frizzled Related Protein-1 For Treatment Of Glaucoma
App 20150307882 - Clark; Abbot F. ; et al. | 2015-10-29 |
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis
Grant 9,139,834 - Chatterton , et al. September 22, 2 | 2015-09-22 |
Transferrin/transferrin receptor-mediated siRNA delivery
Grant 9,114,152 - Chatterton , et al. August 25, 2 | 2015-08-25 |
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
App 20150225720 - Clark; Abbot F. ; et al. | 2015-08-13 |
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
Grant 9,040,494 - Clark , et al. May 26, 2 | 2015-05-26 |
RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
App 20150057336 - Chatterton; Jon E. ; et al. | 2015-02-26 |
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
App 20140357692 - Clark; Abbot F. ; et al. | 2014-12-04 |
RNAi-RELATED INHIBITION OF TNF alpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
App 20140357696 - Chatterton; Jon E. ; et al. | 2014-12-04 |
RNAi-related inhibition of TNF.alpha. signaling pathway for treatment of glaucoma
Grant 8,865,670 - Chatterton , et al. October 21, 2 | 2014-10-21 |
RNAi-related inhibition of TNF.alpha. signaling pathway for treatment of ocular angiogenesis
Grant 8,754,202 - Chatterton , et al. June 17, 2 | 2014-06-17 |
TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
App 20130177580 - Chatterton; Jon E. ; et al. | 2013-07-11 |
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
App 20130123337 - Clark; Abbot F. ; et al. | 2013-05-16 |
Transferrin/transferrin receptor-mediated siRNA delivery
Grant 8,399,653 - Chatterton , et al. March 19, 2 | 2013-03-19 |
Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
Grant 8,389,496 - Clark , et al. March 5, 2 | 2013-03-05 |
RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
App 20120178794 - Chatterton; Jon E. ; et al. | 2012-07-12 |
Rnai-mediated Inhibition Of Frizzled Related Protein-1 For Treatment Of Glaucoma
App 20120178795 - Clark; Abbot F. ; et al. | 2012-07-12 |
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
App 20120122961 - Clark; Abbot F. ; et al. | 2012-05-17 |
Control Of Intraocular Pressure Using Alk5 Modulation Agents
App 20120115870 - Fleenor; Debra L. ; et al. | 2012-05-10 |
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
Grant 8,173,617 - Clark , et al. May 8, 2 | 2012-05-08 |
RNAi-mediated inhibition of Rho kinase for treatment of ocular disorders
Grant 8,168,609 - Chatterton , et al. May 1, 2 | 2012-05-01 |
Use of chemical chaperones to treat glaucoma caused by misfolded or misprocessed proteins
App 20120101160 - Shepard; Allan ; et al. | 2012-04-26 |
Rnai-mediated Inhibition Of Gremlin For Treatment Of Iop-related Conditions
App 20120077864 - Chatterton; Jon E. ; et al. | 2012-03-29 |
Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
App 20120064532 - CLARK; Abbot F. ; et al. | 2012-03-15 |
Bone Morphogenic Proteins (bmp), Bmp Receptors And Bmp Binding Proteins And Their Use In The Diagnosis And Treatment Of Glaucoma
App 20120059049 - CLARK; Abbot F. ; et al. | 2012-03-08 |
Method of treating glaucoma comprising administering a composition comprising human BMP7
Grant 8,063,013 - Clark , et al. November 22, 2 | 2011-11-22 |
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
App 20110257248 - Chatterton; Jon E. ; et al. | 2011-10-20 |
TRANSFERRIN/TRANSFERRIN RECEPTOR-MEDIATED siRNA DELIVERY
App 20110256156 - Chatterton; Jon E. ; et al. | 2011-10-20 |
RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
App 20110245319 - Chatterton; Jon E. ; et al. | 2011-10-06 |
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA
App 20110190376 - Chatterton; Jon E. ; et al. | 2011-08-04 |
Rnai-mediated Inhibition Of Frizzled Related Protein-1 For Treatment Of Glaucoma
App 20110190381 - Clark; Abbot F. ; et al. | 2011-08-04 |
Transferrin/transferrin receptor-mediated siRNA delivery
Grant 7,973,019 - Chatterton , et al. July 5, 2 | 2011-07-05 |
Control Of Intraocular Pressure Using Alk5 Modulation Agents
App 20110160210 - Fleenor; Debra L. ; et al. | 2011-06-30 |
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
App 20110135579 - Chatterton; Jon E. ; et al. | 2011-06-09 |
Rnai-mediated Inhibition Of Ocular Hypertension Targets
App 20110124708 - Shepard; Allan R. ; et al. | 2011-05-26 |
RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
Grant 7,947,660 - Clark , et al. May 24, 2 | 2011-05-24 |
Single Nucleotide Polymorphisms And Genes Associated With Age-related Macular Degeneration
App 20110104154 - Clark; Abbot F. ; et al. | 2011-05-05 |
Pai-1 Expression And Activity Inhibitors For The Treatment Of Ocular Disorders
App 20110105574 - Fleenor; Debra L. ; et al. | 2011-05-05 |
Agents Which Regulate, Inhibit, Or Modulate The Activity And/or Expression Of Connective Tissue Growth Factor (ctgf) As A Unique Means To Both Lower Intraocular Pressure And Treat Glaucomatous Retinopathies/optic Neuropathies
App 20110092523 - Fleenor; Debra L. ; et al. | 2011-04-21 |
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
App 20110054008 - Clark; Abbot F. ; et al. | 2011-03-03 |
Rnai-mediated Inhibition Of Gremlin For Treatment Of Iop-related Conditions
App 20100305193 - Chatterton; Jon E. ; et al. | 2010-12-02 |
Use Of Inhibitors Of Jun N-terminal Kinases For The Treatment Of Glaucomatous Retinopathy And Ocular Diseases
App 20100280089 - Pang; Iok-Hou ; et al. | 2010-11-04 |
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
App 20100267811 - Chatterton; Jon E. ; et al. | 2010-10-21 |
Pai-1 Binding Modulators For The Treatment Of Ocular Disorders
App 20100260784 - Fleenor; Debra L. ; et al. | 2010-10-14 |
Superoxide dismutase-2 expression for glaucoma diagnosis
Grant 7,807,363 - Wang , et al. October 5, 2 | 2010-10-05 |
Diagnostics and therapeutics for glaucoma
Grant 7,807,355 - Clark , et al. October 5, 2 | 2010-10-05 |
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders
App 20100247548 - Shepard; Allan R. ; et al. | 2010-09-30 |
Bone Morphogenic Proteins (bmp), Bmp Receptors And Bmp Binding Proteins And Their Use In The Diagnosis And Treatment Of Glaucoma
App 20100204086 - CLARK; Abbot F. ; et al. | 2010-08-12 |
RNAi-MEDIATED INHIBITION OF TUMOR NECROSIS FACTOR ALPHA-RELATED CONDITIONS
App 20100166676 - Shepard; Allan R. ; et al. | 2010-07-01 |
Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin
Grant 7,744,873 - Clark , et al. June 29, 2 | 2010-06-29 |
RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma
App 20100152279 - Clark; Abbot F. ; et al. | 2010-06-17 |
Use Of Serum Amyloid A Gene In Diagnosis And Treatment Of Glaucoma And Identification Of Anti-glaucoma Agents
App 20100063052 - Clark; Abbot F. ; et al. | 2010-03-11 |
Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
Grant 7,662,389 - Clark , et al. February 16, 2 | 2010-02-16 |
RNAi-Mediated Inhibition of Ocular Targets
App 20090326044 - Shepard; Allan R. ; et al. | 2009-12-31 |
Inhibitors Of Glycogen Synthase Kinase-3 (gsk-3) For Treating Glaucoma
App 20090312390 - Hellberg; Mark R. ; et al. | 2009-12-17 |
RNAi-Mediated Inhibition of RHO Kinase for Treatment of Ocular Disorders
App 20090275641 - Chatterton; Jon E. ; et al. | 2009-11-05 |
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
Grant 7,598,288 - Hellberg , et al. October 6, 2 | 2009-10-06 |
RNAi-mediated inhibition of ocular targets
Grant 7,592,324 - Shepard , et al. September 22, 2 | 2009-09-22 |
Diagnostics and Therapeutics For Glaucoma
App 20090226425 - Clark; Abbot F. ; et al. | 2009-09-10 |
RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20090209627 - Chatterton; Jon E. ; et al. | 2009-08-20 |
Use Of Steroids To Treat Persons Suffering From Ocular Disorders
App 20090181933 - Bingaman; David P. ; et al. | 2009-07-16 |
Complement C1Q Inhibitors For The Prevention And Treatment Of Glaucoma
App 20090117098 - SHEPARD; Allan R. ; et al. | 2009-05-07 |
RNAi-RELATED INHIBITION OF TNFalpha SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS
App 20090036396 - Chatterton; Jon E. ; et al. | 2009-02-05 |
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA
App 20090035225 - Chatterton; Jon E. ; et al. | 2009-02-05 |
RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF MACULAR EDEMA
App 20090036397 - Chatterton; Jon E. ; et al. | 2009-02-05 |
Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
App 20090036371 - CLARK; Abbot F. ; et al. | 2009-02-05 |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20080214486 - Chatterton; Jon E. ; et al. | 2008-09-04 |
Bone Morphogenic Proteins (bmp), Bmp Receptors And Bmp Binding Proteins And Their Use In The Diagnosis And Treatment Of Glaucoma
App 20080194515 - CLARK; Abbot F. ; et al. | 2008-08-14 |
Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
Grant 7,405,192 - Clark , et al. July 29, 2 | 2008-07-29 |
Agents Which Regulate, Inhibit, Or Modulate The Activity And/or Expression Of Connective Tissue Growth Factor (ctgf) As A Unique Means To Both Lower Intraocular Pressure And Treat Glaucomatous Retinopathies/optic Neuropathies
App 20080176964 - Fleenor; Debra L. ; et al. | 2008-07-24 |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20080171719 - Chatterton; Jon E. ; et al. | 2008-07-17 |
Inhibitors Of Protein Kinase C-delta For The Treatment Of Glaucoma
App 20080153903 - FLEENOR; Debra L. ; et al. | 2008-06-26 |
Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
Grant 7,384,926 - Pang , et al. June 10, 2 | 2008-06-10 |
Pai-1 Binding Modulators For The Treatment Of Ocular Disorders
App 20080107644 - FLEENOR; Debra L. ; et al. | 2008-05-08 |
Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
Grant 7,357,931 - Clark , et al. April 15, 2 | 2008-04-15 |
Superoxide Dismutase-2 Expression And Modulation For Glaucoma Diagnosis And Therapy
App 20080085878 - WANG; Wan-Heng ; et al. | 2008-04-10 |
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
Grant 7,351,407 - Fleenor , et al. April 1, 2 | 2008-04-01 |
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders
App 20080057072 - SHEPARD; Allan R. ; et al. | 2008-03-06 |
Rnai-mediated Inhibition Of Gremlin For Treatment Of Iop-related Conditions
App 20080051361 - Chatterton; Jon E. ; et al. | 2008-02-28 |
Use Of Non-feminizing Estrogens As Retinoprotective Agents For The Treatment Of Glaucoma
App 20070225263 - Pang; Iok-Hou ; et al. | 2007-09-27 |
Use of Serum Amyloid A Gene in Diagnosis and Treatment of Glaucoma and Identification of Anti-Glaucoma Agents
App 20070208043 - Clark; Abbot F. ; et al. | 2007-09-06 |
RNAi-mediated inhibition of RHO kinase for treatment of ocular disorders
App 20070149473 - Chatterton; Jon E. ; et al. | 2007-06-28 |
C3-Convertase Inhibitors for the Prevention and Treatment of Age-Related Macular Degeneration in Patients With At Risk Variants Of Complement Factor H
App 20070149616 - Clark; Abbot F. ; et al. | 2007-06-28 |
Control Of Intraocular Pressure Using Alk5 Modulation Agents
App 20070142376 - FLEENOR; Debra L. ; et al. | 2007-06-21 |
Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
Grant 7,220,546 - Clark , et al. May 22, 2 | 2007-05-22 |
Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
App 20060275797 - Shepard; Allan R. ; et al. | 2006-12-07 |
RNAi-mediated inhibition of Frizzled Related Protein-1 for treatment of glaucoma
App 20060223773 - Clark; Abbot F. ; et al. | 2006-10-05 |
Diagnostics and therapeutics for glaucoma
App 20060216732 - Clark; Abbot F. ; et al. | 2006-09-28 |
RNAi inhibition of serum amyloid a for treatment of glaucoma
App 20060172961 - Clark; Abbot F. ; et al. | 2006-08-03 |
RNAi-mediated inhibition of ocular targets
App 20060172965 - Shepard; Allan R. ; et al. | 2006-08-03 |
RNAi-mediated inhibition of ocular hypertension targets
App 20060172963 - Shepard; Allan R. ; et al. | 2006-08-03 |
Method of reducing intraocular pressure and treating glaucoma
App 20060154981 - Klimko; Peter G. ; et al. | 2006-07-13 |
Use of steroids to treat ocular disorders
App 20060154910 - Bingaman; David P. ; et al. | 2006-07-13 |
Use of AP-1 activators to treat glaucoma and ocular hypertension
App 20060142379 - Shade; Debra L. ; et al. | 2006-06-29 |
Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (LOX) and LOX-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
App 20060134172 - Shepard; Allan ; et al. | 2006-06-22 |
Agents which regulate, inhibit, or modulate the activity and/or expression of formyl peptide receptors as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
App 20060134171 - McNatt; Loretta G. ; et al. | 2006-06-22 |
Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
App 20060094753 - Pang; Iok-Hou ; et al. | 2006-05-04 |
Diagnostics and therapeutics for glaucoma
Grant 7,033,755 - Clark , et al. April 25, 2 | 2006-04-25 |
Use of AP-1 activators to treat glaucoma and ocular hypertension
Grant 7,005,446 - Shade , et al. February 28, 2 | 2006-02-28 |
Use of cathepsin k inhibitors for the treatment of glaucoma
App 20060020001 - Shepard; Allan ; et al. | 2006-01-26 |
Methods for diagnosing glaucoma and discovering anti-glaucoma drugs
App 20050255476 - Clark, Abbot F. ; et al. | 2005-11-17 |
Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
App 20050234075 - Fleenor, Debra L. ; et al. | 2005-10-20 |
Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/ca2+ signaling pathway
App 20050170430 - Clark, Abbot F ; et al. | 2005-08-04 |
Diagnosis and treatment of glaucoma and methods for discovering new glaucoma therapeutic agents based on the wnt/planar cell polarity (pcp) signaling pathway
App 20050164907 - Clark, Abbot F ; et al. | 2005-07-28 |
Short form c-Maf transcription factor antagonists for treatment of glaucoma
App 20050159432 - Shepard, Allan R. ; et al. | 2005-07-21 |
Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
App 20050153927 - Clark, Abbot F. ; et al. | 2005-07-14 |
Bone morphogenic proteins (bmp),bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
App 20050118585 - Clark, Abbot F. ; et al. | 2005-06-02 |
Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
App 20040214806 - Pang, Iok-Hou ; et al. | 2004-10-28 |
Use of steroids to treat persons suffering from ocular disorders
App 20040171598 - Bingaman, David P. ; et al. | 2004-09-02 |
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
App 20040167109 - Bingaman, David P. ; et al. | 2004-08-26 |
Use of ADNP for the treatment of glaucomatous optic neuropathy
App 20030166544 - Clark, Abbot F. ; et al. | 2003-09-04 |
Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
App 20030134308 - Clark, Abbot F. ; et al. | 2003-07-17 |
Vasoactive intestinal peptides for glaucomatous retinopathy
App 20030113270 - Clark, Abbot F. | 2003-06-19 |
Use of aminoglycosides to treat genetic ophthalmic diseases that are associated with premature termination mutations
App 20020123470 - Clark, Abbot F. | 2002-09-05 |
Sub-tenon drug delivery
Grant 6,413,245 - Yaacobi , et al. July 2, 2 | 2002-07-02 |
Diagnostics and therapeutics for glaucoma
App 20020049177 - Clark, Abbot F. ; et al. | 2002-04-25 |
Methods For Diagnosing Glaucoma And Discovering Anti-glaucoma Drugs
App 20020042050 - CLARK, ABBOT F. ; et al. | 2002-04-11 |
Use of ADNF for the treatment of retinal or optic nerve head damage
App 20020028763 - Shade, Debra L. ; et al. | 2002-03-07 |
Treatment of glaucoma and ocular hypertension
Grant 6,177,427 - Clark , et al. January 23, 2 | 2001-01-23 |
Combination therapy for lowering and controlling intraocular pressure
Grant 6,172,054 - Clark January 9, 2 | 2001-01-09 |
TGF.alpha. for the treatment of ocular hypertension and glaucoma
Grant 6,071,875 - Clark , et al. June 6, 2 | 2000-06-06 |
Angiostatic agents and methods and compositions for controlling ocular hypertension
Grant 5,990,099 - Clark November 23, 1 | 1999-11-23 |
A-seco steroids effective at treating ophthalmic pathological neovascularization and controlling intraocular pressure
Grant 5,929,111 - Conrow , et al. July 27, 1 | 1999-07-27 |
Prevention and treatment of ocular neovascularization using angiostatic steroids
Grant 5,770,592 - Clark June 23, 1 | 1998-06-23 |
Angiostatic steroids and methods and compositions for controlling ocular hypertension
Grant 5,698,545 - Clark , et al. December 16, 1 | 1997-12-16 |
Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
Grant 5,686,621 - Clark , et al. November 11, 1 | 1997-11-11 |
Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids
Grant 5,679,666 - Clark October 21, 1 | 1997-10-21 |
Estrogen metabolites for lowering intraocular pressure
Grant 5,521,168 - Clark May 28, 1 | 1996-05-28 |
Ophthalmic composition
Grant 5,407,926 - Clark * April 18, 1 | 1995-04-18 |
Angiostatic steroids and methods and compositions for controlling ocular hypertension
Grant 5,371,078 - Clark , et al. December 6, 1 | 1994-12-06 |
Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
Grant 4,945,089 - Clark July 31, 1 | 1990-07-31 |
Methods for controlling ocular hypertension with angiostatic steroids
Grant 4,876,250 - Clark October 24, 1 | 1989-10-24 |
| 